Reasons for the switch from a first anti-TNF-alpha antibody to a second anti-TNF-alpha antibody in these patients were allergic reactions (n = 30; 65.2%), intolerance (n = 3; 6.5%) and loss of response (n = 13; 28.3%). The gene discussed is TNF; the disease is allergic disease.